Perfil
James Ballance worked as a Director of Business Development at Aventis Behring from 1999 to 2001.
He was the Vice President of Scientific Affairs at PhaseBio Pharmaceuticals, Inc. in 2013 and 2014.
He was also the Head of Research and Development at Delta Biotechnology Ltd.
Additionally, he worked as the Vice President of Technology Development at BioRexis Pharmaceutical Corp.
from 2003 to 2007.
Dr. Ballance received his undergraduate degree from the University of Wales (Bangor) in 1981 and his doctorate from the University of Bristol in 1984.
Antiguos cargos conocidos de James Ballance.
| Empresas | Cargo | Fin |
|---|---|---|
BioRexis Pharmaceutical Corp.
 BioRexis Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology BioRexis Pharmaceutical Corp. provides novel protein and peptide drugs with pharmacology and trans-bodies to replace conventional monoclonal antibodies. The company was founded by Christopher P. Prior, Andrew Turner and David R. King in 2002 and is headquartered in Rosemont, PA. | Chief Tech/Sci/R&D Officer | 01/12/2007 |
| Aventis Behring | Corporate Officer/Principal | 01/01/2001 |
| PHASEBIO PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | - |
Delta Biotechnology Ltd.
 Delta Biotechnology Ltd. Pharmaceuticals: OtherHealth Technology Part of Novonesis A/S, Delta Biotechnology Ltd. is a British company that produces and markets a range of valuable proteins from yeast using low-cost manufacturing technologies. The private company is based in Windlesham, UK. Delta Biotechnology was acquired by Novozymes A/S on July 06, 2006. | Chief Tech/Sci/R&D Officer | - |
Formación de James Ballance.
| University of Wales (Bangor) | Undergraduate Degree |
| University of Bristol | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| PHASEBIO PHARMACEUTICALS, INC. | Health Technology |
| Empresas privadas | 3 |
|---|---|
Delta Biotechnology Ltd.
Delta Biotechnology Ltd. Pharmaceuticals: OtherHealth Technology Part of Novonesis A/S, Delta Biotechnology Ltd. is a British company that produces and markets a range of valuable proteins from yeast using low-cost manufacturing technologies. The private company is based in Windlesham, UK. Delta Biotechnology was acquired by Novozymes A/S on July 06, 2006. | Health Technology |
| Aventis Behring | Health Technology |
BioRexis Pharmaceutical Corp.
BioRexis Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology BioRexis Pharmaceutical Corp. provides novel protein and peptide drugs with pharmacology and trans-bodies to replace conventional monoclonal antibodies. The company was founded by Christopher P. Prior, Andrew Turner and David R. King in 2002 and is headquartered in Rosemont, PA. | Health Technology |
- Bolsa de valores
- Insiders
- James Ballance
